1. Chochola M, Linhart A. Epidemiology of ischemic diseases of the lower extremities. Čas Lék čes 2006; 145: 368–370.
2. Chochola M, Pytlík R, Kobylka P et al. Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia. Int Angiol 2008; 27: 281–290.
3. Norgren L, Hiatt WR, Dormandy JA et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl. 1): S1–S75.
4. Campbell WB, Ridler BM, Szymanska TH. Current management of acute leg ischaemia: results of an audit by the Vascular Surgical Society of Great Britain and Ireland. Br J Surg 1998; 85: 1498–1503.
5. Berridge DC, Kessel D, Robertson I. Surgery versus thrombolysis for acute limb ischaemia: initial management. Cochrane Database Syst Rev 2002: CD002784(1).
6. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998; 338: 1105–1111.
7. Korn P, Khilnani NM, Fellers JC et al. Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J Vasc Surg 2001; 33: 1148e–1157e.
8. Klein AJ, Chen SJ, Messenger JC et al. Quantitative assessment of the conformational change in the femoropopliteal artery with leg movement. Catheter Cardiovasc Interv 2009; 74: 787–798.
9. Lewitton S, Babaev A. Superficial femoral artery stent fracture that led to perforation, hematoma and deep venous thrombosis. J Invasive Cardiol 2008; 20: 479–481.
10. Arena FJ. Arterial kink and damage in normal segments of the superficial femoral and popliteal arteries abutting nitinol stents – a common cause of late occlusion and restenosis? A single-center experience. J Invasive Cardiol 2005; 17: 482–486.